Cargando…
Effects of gut microbiota on in vivo metabolism and tissue accumulation of cytochrome P450 3A metabolized drug: Midazolam
The link between drug‐metabolizing enzymes and gut microbiota is well established. In particular, hepatic cytochrome P450 (CYP) 3A activities are presumed to be affected by gut microbiota. However, there is no direct evidence that the gut microbiota affects CYP3A metabolism or the clearance of clini...
Autores principales: | Togao, Masao, Kawakami, Koji, Otsuka, Jun, Wagai, Gaku, Ohta‐Takada, Yuki, Kado, Shoichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497050/ https://www.ncbi.nlm.nih.gov/pubmed/32562497 http://dx.doi.org/10.1002/bdd.2244 |
Ejemplares similares
-
Normal variation of the gut microbiota affects hepatic cytochrome P450 activity in mice
por: Togao, Masao, et al.
Publicado: (2021) -
Development of incident severity classification for laboratory animals
por: Wagai, Gaku, et al.
Publicado: (2021) -
Homotropic Cooperativity of Midazolam Metabolism by
Cytochrome P450 3A4: Insight from Computational Studies
por: Li, Junhao, et al.
Publicado: (2021) -
Characteristics of cytochrome P450-dependent metabolism in the liver of the
wild raccoon, Procyon lotor
por: SHINYA, So, et al.
Publicado: (2022) -
Cytochrome P450 Enzymes and Drug Metabolism in Humans
por: Zhao, Mingzhe, et al.
Publicado: (2021)